Health insurance fund to cover several Hepatitis C drugs
Several new-generation drugs for hepatitis C treatment will be covered by the health insurance fund as part of a recently-released circular by the Ministry of Health.
A health worker collects a blood sample for hepatitis C test (Photo: VNA)
Hanoi (VNA) - Several new-generationdrugs for hepatitis C treatment will be covered by the health insurance fund aspart of a recently-released circular by the Ministry of Health.
After consulting with experts and leadinghospitals, the health and insurance sector agreed to bring new drugs forhepatitis C treatment into the list of medicine covered by health insurancefund, said Prof. Nguyen Van Kinh, Director of the National Hospital of TropicalDiseases.
Kinh said that the new medications help shortentreatment duration because they are effective and have fewer side effects.
The inclusion of new drugs to treat hepatitis Con the list covered by health insurance opens more opportunities for Vietnamesepatients to access advanced treatments, he said.
Nguyen Trong Khoa, Deputy Director of the HealthMinistry’s Preventive Medicine Department, said Vietnam ranks 4th in the worldin terms of mortality from liver cancer. The country has about one millionpeople infected with hepatitis C virus and 10 million infected with hepatitisB, so the community’s need for treatment services is increasing day by day, hesaid.
The practice is an important milestone toachieve the goal to eliminate hepatitis by 2030 and reduce the burden of liverdiseases in Vietnam, said Khoa, adding that hepatitis C and hepatitis B are themain causes of liver diseases in Vietnam.
Antiviral medicines can cure more than 95 percentof people with hepatitis C, thereby reducing the risk of death from livercancer and cirrhosis, but access to diagnosis and treatment is low, accordingto Khoa.
Khoa said the Health Ministry also worked withforeign pharmaceutical companies to franchise drug production and boostproduction in Vietnam at a cheaper price, creating favourable conditions forpatients to access treatments for liver diseases.
Hepatitis C is a liver disease caused by hepatitisC virus, according to the World Health Organisation (WHO).
According to WHO, some 71 million people havechronic hepatitis C infections globally whereas about 399,000 people die eachyear from hepatitis C, mostly from cirrhosis and hepatocellular carcinoma.-VNA
Vietnam has expanded health insurance coverage among HIV patients taking ARV treatment to 83.4 percent at present from 50 percent in 2016, helping ensure that they can maintain long-term treatment.
About 90 percent of social insurance funds are currently invested in government bonds (G-bonds), Dao Viet Anh, Deputy General Director of the Vietnam Social Security (VSS), said at a seminar last week.
Hanoi’s health insurance fund suffered a deficit of more than 500 billion VND (21.4 million USD) in the first half of this year, said Nguyen Duc Hoa, director of Hanoi Social Insurance.
As many as 89 percent of HIV/AIDS patients receiving antiretroviral drug (ARV) treatment in Vietnam have signed up for health insurance cards so far, with the figure expected to exceed 90 percent by the end of this year.
An estimated 800,000 people in Vietnam suffer from obstructive sleep apnea syndrome (OSAS), which requires expensive polysomnography and respiratory polygraphy screening tests.
Vietnam now boasts a nationwide healthcare network with 1,665 hospitals, 384 of which are non-public, supported by local commune- and ward-level stations. At the end of 2024, hospital bed capacity reached 34 per 10,000 people, slightly above the global average.
The 56-year-old patient from Quang Tri province was discharged in stable condition as he no longer experienced shortness of breath and was able to walk, move around, and eat normally.
Associate Professor Dr. Nguyen Vu Trung, Director of the Pasteur Institute, said that under the MoU, the two sides committed to promoting diverse and practical collaborative activities, including joint conferences and workshops, exchanges of scholars, researchers and students, sharing academic materials, and the development of specific programmes and projects in scientific research, training, and epidemic prevention.
TytoCare, a leading Israeli telemedicine company based in Netanya, is willing to work with Vietnamese regulators, insurers, and healthcare providers to develop a sustainable digital health ecosystem.
The partnership is under the framework of a Memorandum of Understanding on the development and implementation of the National Action Plan on Breast Cancer and Cervical Cancer Prevention and Control, signed in Hanoi on July 22.
An estimated 7 million Vietnamese are currently living with diabetes, but about 50% remain undiagnosed, a dangerous gap that is fuelling serious, preventable complications and increasing the burden on the healthcare system.
In 2024, Vietnam achieved 99% coverage for the first dose of the diphtheria, tetanus and pertussis vaccine, up from 80% in 2023. Immunisation coverage in the country has not only rebounded to the high levels seen before the COVID-19 pandemic but has now surpassed the rates recorded in 2019.
Health authorities in HCM City have issued an urgent alert after six people died from dengue fever, amid a spike in infections driven by the onset of the rainy season.
During the peak months of July and August 2025, the National Institute of Haematology and Blood Transfusion (NIHBT) needs at least 90,000 units of blood to supply 180 hospitals in the northern region. However, despite continuous efforts, the reserve blood is still short of 30,000 units.
The Hanoi ceremony highlighted efforts to ensure all citizens, especially women and youth, can access accurate information and healthcare services to make informed reproductive choices.
After such a long time, the law has revealed many limitations, prompting the Ministry of Health (MoH) to gather opinions to amend the law to give more chances to thousands of patients every year.
Currently, cardiovascular specialists from the 108 Military Central Hospital are working alongside a team of Prof.Dr. Jan D. Schmitto, Deputy Director of MHH’s Department of Cardiac, Thoracic, Transplantation and Vascular Surgery on clinical trials for MCS devices, implanted in heart failure patients either as a bridge to transplantation or as permanent treatment.
The centre not only serves residents living on the island, but also receives tens of thousands of visitors every year, according to Assoc Prof Dr Tang Chi Thuong, Director of the HCM CIty Department of Health.
Not only does Vietnam attract international tourists with its landscapes, culture, and cuisine, but it is also gradually becoming a reliable destination for medical treatment, offering high-quality services at reasonable costs.
Over the past six months, 150 communal health stations in provinces including Ha Giang, Bac Kan, Lang Son, Lao Cai, Lai Chau, Yen Bai, Tay Ninh, Hau Giang, Ben Tre and Ca Mau have been equipped with information technology systems. In addition, 117 key provincial healthcare workers have received training, with thousands more expected to follow.
During the COVID-19 pandemic in 2020, the Ministry of Health swiftly launched a telemedicine programme, connecting more than 1,000 medical establishments nationwide. The model, which remains in operation, has benefited tens of thousands of patients, including foreign nationals.
After more than three weeks of intensive treatment, the patient's pneumonia improved, breathing stabilised, sedation was reduced, and the breathing tube was removed. He is now conscious, able to eat orally, and in recovery.
A health worker collects a blood sample for hepatitis C test (Photo: VNA)
